References
- Lomax A. Intensity modulation methods for proton radiotherapy. Phys Med Biol. 1999;44(1):185–205.
- Lomax AJ, Boehringer T, Coray A, et al. Intensity modulated proton therapy: a clinical example. Med Phys. 2001;28(3):317–324.
- Zhang X, Li Y, Pan X, et al. Intensity-modulated proton therapy reduces the dose to normal tissue compared with intensity-modulated radiation therapy or passive scattering proton therapy and enables individualized radical radiotherapy for extensive stage IIIB non-small-cell lung cancer: a virtual clinical study. Int J Radiat Oncol. 2010;77(2):357–366.
- Chang JY, Li H, Zhu XR, et al. Clinical implementation of intensity modulated proton therapy for thoracic malignancies. Int J Radiat Oncol Biol Phys. 2014;90(4):809–818.
- Liu W, Li Y, Li X, et al. Influence of robust optimization in intensity-modulated proton therapy with different dose delivery techniques. Med Phys. 2012;39(6):3089–3101.
- Liu W, Frank SJ, Li X, et al. Effectiveness of robust optimization in intensity-modulated proton therapy planning for head and neck cancers: robust optimization for IMPT for H&N cancer. Med Phys. 2013;40(5):051711.
- Langen K, Zhu M. Concepts of PTV and robustness in passively scattered and pencil beam scanning proton therapy. Semin Radiat Oncol. 2018;28(3):248–255.
- Lomax AJ. Intensity modulated proton therapy and its sensitivity to treatment uncertainties 2: the potential effects of inter-fraction and inter-field motions. Phys Med Biol. 2008;53(4):1043–1056.
- Unkelbach J, Bortfeld T, Martin BC, et al. Reducing the sensitivity of IMPT treatment plans to setup errors and range uncertainties via probabilistic treatment planning: optimizing IMPT plans under uncertainty. Med Phys. 2008;36(1):149–163.
- Fredriksson A, Forsgren A, Hårdemark B. Minimax optimization for handling range and setup uncertainties in proton therapy: minimax optimization for handling uncertainties in proton therapy. Med Phys. 2011;38(3):1672–1684.
- Moignier A, Gelover E, Wang D, et al. Theoretical benefits of dynamic collimation in pencil beam scanning proton therapy for brain tumors: dosimetric and radiobiological metrics. Int J Radiat Oncol Biol Phys. 2016;95(1):171–180.
- Albertini F, Gaignat S, Bosshardt M, et al. Planning and optimizing treatment plans for actively scanned proton therapy. In: Biomedical mathematics: promising directions in imaging, therapy planning and inverse problems. Medical Physics Publishing; 2010. Chapter 1; p. 1–18.
- van de Water S, Kooy HM, Heijmen BJM, et al. Shortening delivery times of intensity modulated proton therapy by reducing proton energy layers during treatment plan optimization. Int J Radiat Oncol. 2015;92(2):460–468.
- Ding X, Li X, Qin A, et al. Redefine the role of range shifter in treating bilateral head and neck cancer in the era of intensity modulated proton therapy. J Appl Clin Med Phys. 2018;19:749–755.
- Ding X, Li X, Zhang JM, et al. Spot-scanning proton arc (SPArc) therapy: the first robust and delivery-efficient spot-scanning proton arc therapy. Int J Radiat Oncol Biol Phys. 2016;96(5):1107–1116.
- Li X, Liu G, Janssens G, et al. The first prototype of spot-scanning proton arc treatment delivery. Radiother Oncol. 2019;137:130–136.
- Ding X, Li X, Qin A, et al. Have we reached proton beam therapy dosimetric limitations? – A novel robust, delivery-efficient and continuous spot-scanning proton arc (SPArc) therapy is to improve the dosimetric outcome in treating prostate cancer. Acta Oncol. 2018;57(3):435–437.
- Li X, Kabolizadeh P, Yan D, et al. Improve dosimetric outcome in stage III non-small-cell lung cancer treatment using spot-scanning proton arc (SPArc) therapy. Radiat Oncol. 2018;13(1):35.
- Ding X, Zhou J, Li X, et al. Improving dosimetric outcome for hippocampus and cochlea sparing whole brain radiotherapy using spot-scanning proton arc therapy. Acta Oncol. 2019;58(4):483–490.
- Liu G, Li X, Qin A, et al. Improve the dosimetric outcome in bilateral head and neck cancer (HNC) treatment using spot-scanning proton arc (SPArc) therapy: a feasibility study. Radiat Oncol. 2020;15(1):21.
- Schippers JM, Lomax AJ. Emerging technologies in proton therapy. Acta Oncol. 2011;50(6):838–850.
- Han W, Liu X, Qin B, et al. Design considerations of a fast kicker system applied in a proton therapy beamline. Nucl Instrum Methods Phys Res A. 2019;940:199–205.
- Tani N, Adachi T, Someya H, et al. Eddy current effect of magnets for J-PARC 3-GeV synchrotron. IEEE Trans Appl Supercond. 2004;14(2):421–424.
- Liu X, Qin B, Liu K, et al. Eddy current analysis and optimization of fast scanning magnet for a proton therapy system. Nucl Instrum Methods Phys Res Sect Accel Spectromet Detect Assoc Equip. 2017;862:1–7.
- Farr JB, Flanz JB, Gerbershagen A, et al. New horizons in particle therapy systems. Med Phys. 2018;45(11):e953–e983.
- Schippers JM, Seidel M. Operational and design aspects of accelerators for medical applications. Phys Rev Spec Top Accel Beams. 2015;18:034801.
- Van de Walle J, Abs M, Conjat M, et al. The S2C2: from source to extraction. In: Proceedings of the 21st International Conference on Cyclotrons and Their Applications (Cyclotrons’16); 2016; Zurich, Switzerland. p. 285–289. Available from: https://accelconf.web.cern.ch/cyclotrons2016/papers/thb01.pdf
- Low DA, Harms WB, Mutic S, et al. A technique for the quantitative evaluation of dose distributions. Med Phys. 1998;25(5):656–661.
- Shen J, Tryggestad E, Younkin JE, et al. Technical note: using experimentally determined proton spot scanning timing parameters to accurately model beam delivery time. Med Phys. 2017;44(10):5081–5088.